Detalhe da pesquisa
1.
Integration of Multi-omic Data in a Molecular Tumor Board Reveals EGFR-Associated ALK-Inhibitor Resistance in a Patient With Inflammatory Myofibroblastic Cancer.
Oncologist
; 28(8): 730-736, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37255276